文献速递腹部CT

动态对比增强CT衍生的细胞外容积分数预测胰腺导管腺癌术后肿瘤学结局

Dynamic contrast-enhanced CT-derived extracellular volume fraction for predicting postoperative oncologic outcomes in pancreatic ductal adenocarcinoma.
PubMed 文献 · Eur J Radiol · 2025-06-18

回顾性纳入71例胰腺导管腺癌术后患者,术前接受新辅助化疗前完成CT平扫及平衡期扫描,计算非癌胰腺实质和肿瘤的细胞外容积分数(fECV)。非癌胰腺实质fECV是总生存的独立预后因素,高fECV组无复发生存和总生存更差;TNM分期IB是复发的独立预测因素。

要点

  • 非癌胰腺实质fECV是PDAC术后总生存的独立预后因素(p=0.018)。
  • 非癌胰腺实质fECV预测RFS最佳截断值40.32%,预测OS最佳截断值43.65%。
  • 高fECV组(非癌胰腺实质)RFS和OS均较低fECV组更差。

核心结论

  • CT细胞外容积分数测得的非癌胰腺实质fECV是PDAC术后生存结局的显著预测因素。

研究设计与样本

  • 回顾性研究,纳入71例PDAC术后患者(35男,36女;平均年龄70.3岁,95%CI 68.1-72.6;SD 9.8;范围45-89岁),术前新辅助化疗前完成对比增强CT平扫及平衡期扫描;自动分割非癌胰腺实质和胰腺肿瘤(排除局灶病变、大血管和胰管),计算fECV=(100-红细胞压积)×(Δ胰腺/Δ主动脉);采用Cox比例风险模型进行单因素和多因素分析,时间依赖ROC曲线确定最佳截断值。

诊断标准与关键数值

  • 非癌胰腺实质fECV预测RFS最佳截断值40.32%(p=0.036),预测OS最佳截断值43.65%(p<0.001);OS独立预后因素:辅助化疗方案(p<0.001)、组织学类型(p=0.049)、非癌胰腺实质fECV(p=0.018);RFS独立预测因素:TNM分期IB(p=0.025)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the prognostic value of the extracellular volume fraction (fECV) derived from contrast-enhanced computed tomography (CE-CT) for recurrence-free survival (RFS) and overall survival (OS) rates after pancreatic ductal adenocarcinoma (PDAC) surgery.

METHODS: This retrospective study evaluated 71 patients diagnosed with PDAC postsurgery who underwent CE-CT with precontrast and equilibrium phases before neoadjuvant chemotherapy (35 males, 36 females; mean age, 70.3 years; 95 % CI, 68.1-72.6; SD, 9.8; range, 45-89 years), were enrolled. Noncancerous pancreatic parenchyma and pancreatic tumors were automatically segmented from nonenhanced and equilibrium-phase images, excluding focal lesions, major-vessel, and ducts. Uni- and multivariate analyses (Cox proportional hazards model) were performed to evaluate fECV [=(100 - hematocrit) × (ΔPancreas/ΔAorta] in the nonaffected pancreas and tumor, with age, sex, chemotherapeutic scheme, tumor marker/location/size, stage, histological type, RFS, and OS as factors. Time-dependent receiver-operating characteristic curves showed the optimal fECV cutoff values for predicting RFS and OS.

RESULTS: Adjuvant chemotherapy regimen, histological type, and fECV of noncancerous pancreatic parenchyma were independent prognostic factors of OS (p < 0.001, 0.049, and 0.018, respectively), and TNM stage (IB) was an independent predictor of RFS (p = 0.025). RFS and OS were worse in patients with noncancerous pancreatic tissue with higher fECV than in those with lower fECV (optimal cutoffs: 40.32 % for RFS, p = 0.036; 43.65 % for OS, p < 0.001).

CONCLUSION: The fECV of noncancerous pancreatic parenchyma from CE-CT was a significant predictor of survival outcomes in PDAC.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Fukui H, Fukuda Y, Onishi H, et al. Dynamic contrast-enhanced CT-derived extracellular volume fraction for predicting postoperative oncologic outcomes in pancreatic ductal adenocarcinoma. Eur J Radiol. 2025. PMID: 40543284. doi:10.1016/j.ejrad.2025.112246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。